• 62 Citations
  • 4 h-Index
20162019
If you made any changes in Pure these will be visible here soon.

Research Output 2016 2019

  • 62 Citations
  • 4 h-Index
  • 6 Article
  • 5 Abstract/Meeting Abstract
  • 2 Review article
  • 1 Letter
2019
1 Citation (Scopus)

Increasing Incidence of Nonalcoholic Steatohepatitis as an Indication for Liver Transplantation in Australia and New Zealand

Calzadilla-Bertot, L., Jeffrey, G. P., Jacques, B., McCaughan, G., Crawford, M., Angus, P., Jones, R., Gane, E., Munn, S., Macdonald, G., Fawcett, J., Wigg, A., Chen, J., Fink, M. & Adams, L. A., Jan 2019, In : Liver Transplantation. 25, 1, p. 25-34 10 p.

Research output: Contribution to journalArticle

Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease

Bertot, L. C. & Adams, L. A., 1 Feb 2019, In : Expert Review of Gastroenterology and Hepatology. 13, 2, p. 179-187 9 p.

Research output: Contribution to journalReview article

2018

Abide: A Novel Predictive Model of Liver Decompensation in Patients with Non-Alcoholic Fatty Liver Related Cirrhosis.

Bertot, L., Vilar-Gomez, E., Wong, V. W-S., Romero-Gomez, M., Aller-De La Fuente, R., Lai, G., Fernandez, M., Eslam, M., George, J. & Adams, L. A., Oct 2018, In : Hepatology. 68, p. 87A-87A 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Diabetes but Not Metabolic Syndrome Adversely Impact Survival or Liver Decompensation in Patients with Non-Alcoholic Fatty Liver Related Cirrhosis.

Bertot, L., Vilar-Gomez, E., Wong, V. W-S., Romero-Gomez, M., Aller-De La Fuente, R., Lai, G., Fernandez, M., Eslam, M., George, J. & Adams, L. A., Oct 2018, In : Hepatology. 68, p. 20A-21A 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

5 Citations (Scopus)
Fibrosis
Hepatocellular Carcinoma
Liver
Liver Cirrhosis
Liver Transplantation
34 Citations (Scopus)

Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study

Vilar-Gomez, E., Calzadilla-Bertot, L., Wai-Sun Wong, V., Castellanos, M., Aller-de la Fuente, R., Metwally, M., Eslam, M., Gonzalez-Fabian, L., Alvarez-Quiñones Sanz, M., Conde-Martin, A. F., De Boer, B., McLeod, D., Hung Chan, A. W., Chalasani, N., George, J., Adams, L. A. & Romero-Gomez, M., 1 Aug 2018, In : Gastroenterology. 155, 2, p. 443-457.e17

Research output: Contribution to journalArticle

Fibrosis
Cohort Studies
Mortality
Confidence Intervals
Liver
2017
10 Citations (Scopus)

Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis

Vilar-Gomez, E., Calzadilla-Bertot, L., Friedman, S. L., Gra-Oramas, B., Gonzalez-Fabian, L., Villa-Jimenez, O., Lazo-del Vallin, S., Diago, M., Adams, L. A., Romero-Gomez, M. & Chalasani, N., 1 Jan 2017, In : Alimentary Pharmacology and Therapeutics. 45, 2, p. 332-344 13 p.

Research output: Contribution to journalArticle

Fatty Liver
Life Style
Histology
Kidney
Liver
Open Access
Hepatocellular Carcinoma
Fibrosis
Liver Cirrhosis
Liver Diseases
Non-alcoholic Fatty Liver Disease

Non-alcoholic steatohepatitis is an important growing indication for liver transplantation in Australia and New Zealand

Bertot, L. C., Jeffrey, G. P., Delriviere, L. D., McCaughan, G., Crawford, M., Angus, P. W., Jones, R. M., Gane, E. J., Munn, S., Macdonald, G. A., Fawcett, J., Wigg, A. J., Chen, J. & Adams, L. A., Oct 2017, In : Hepatology. 66, p. 907A-908A 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Role of Exercise in NAFLD/NASH: What is the Right Prescription?

Calzadilla Bertot, L. & Adams, L. A., 2017, In : Current Hepatology Reports. 16, 4, p. 356–365

Research output: Contribution to journalReview article

Fatty Liver
Prescriptions
Liver Diseases
Alcoholic Fatty Liver
Diet Therapy
12 Citations (Scopus)

Serum biomarkers can predict a change in liver fibrosis 1 year after lifestyle intervention for biopsy-proven NASH

Vilar-Gomez, E., Calzadilla-Bertot, L., Friedman, S. L., Gra-Oramas, B., Gonzalez-Fabian, L., Lazo-del Vallin, S., Diago, M. & Adams, L. A., 1 Dec 2017, In : Liver International. 37, 12, p. 1887-1896 10 p.

Research output: Contribution to journalArticle

Liver Cirrhosis
Life Style
Fibrosis
Biomarkers
Biopsy

The Long-Term Clinical Course of Histologically Advanced Nonalcoholic Fatty Liver Disease. Impact of Fibrosis Severity on Major Clinical Outcomes.

Vilar-Gomez, E., Bertot, L. C., Wong, V. W., Fernandez, M. I. C., Aller, R., Eslam, M., George, J., Adams, L. A. & Romero-Gomez, M., Oct 2017, In : Hepatology. 66, p. 33A-34A 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Type 2 diabetes and anti-diabetic medications modify the risk of liver-related outcomes in subjects with non-alcoholic fatty liver disease and advanced fibrosis. Results of a multicenter international cohort study.

Bertot, L. C., Gomez, E. V., Wong, V. W., Fernandez, M. C., Aller, R., Eslam, M., George, J., Romero-Gomez, M. & Adams, L. A., Oct 2017, In : Hepatology. 66, p. 1119A-1119A 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

2016

Identifying Patients With Nonalcoholic Steatohepatitis That Are Nonresponders to Therapy Reply

Vilar-Gomez, E., Calzadilla-Bertot, L., Friedman, S. L. & Romero-Gomez, M., 1 Dec 2016, In : Hepatology. 64, 6, p. 2266-2267 2 p.

Research output: Contribution to journalLetter